Resources

Meta-analysis found metformin therapy was associated with decreased risk for colorectal adenomas and colorectal cancer among T2 patients.

Insulin resistance is inversely and independently associated with bone size in young men without diabetes, according to a new study.

Researchers say sleeping BP may be novel target for diabetes prevention.

CV data added to labels for treatments containing empagliflozin.

True or false? Diabetes increases the risk for conjunctivitis. Follow the link to see if you got it right!

Which new drug class have you seen the best results with in lowering A1c’s? 1) DPP-4 2) GLP-4 3) SGLT-2 4) Other Follow the link to see what others think!

When we think about disasters, we usually think of the outcome, a poor health outcome. We don’t always think about the journey. The journey to poor health outcomes are many. Today I am reminded of not having the insurance coverage for the correct medication. Without it, one can have a disaster, poor diabetes management. The consequences of that, as well as the disruption to running a smooth office.

Dr. Altamash Shaikh talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. In part 2 of this Exclusive Interview, Dr. Shaik explains the pervasiveness of diabetes among the younger Indian population and the three reasons for this occurrence.

In this week's Homerun Slides, the cardiovascular outcomes of patients in the placebo vs empagliflozin study.

Insulin receptors, ligand binding: The insulin action sequence is initiated with specific binding to high-affinity receptors on the plasma membrane of target cells. The insulin receptor is a large transmembrane glycoprotein consisting of two alpha- and two beta- subunits that form a heterotetramer, as depicted in Figure 12.1. The insulin receptor is synthesized from a single gene as a polypeptide pro receptor comprised of alpha- and beta- subunit sequences in tandem.